ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04724	Glutamatergic synapse	47/358	152/7206	1.23189731142e-25
ko05033	Nicotine addiction	27/358	56/7206	4.74816069064e-21
ko04728	Dopaminergic synapse	40/358	185/7206	7.95019935164e-16
ko04080	Neuroactive ligand-receptor interaction	58/358	423/7206	4.99578922872e-13
ko04721	Synaptic vesicle cycle	23/358	80/7206	2.60108940033e-12
ko05030	Cocaine addiction	21/358	73/7206	2.36052921078e-11
ko04723	Retrograde endocannabinoid signaling	32/358	175/7206	8.24641888553e-11
ko04727	GABAergic synapse	25/358	110/7206	8.37129504406e-11
ko05031	Amphetamine addiction	22/358	91/7206	3.29422563604e-10
ko04713	Circadian entrainment	27/358	136/7206	3.86879269231e-10
ko05032	Morphine addiction	23/358	110/7206	2.80428624792e-09
ko04024	cAMP signaling pathway	38/358	279/7206	9.31227036368e-09
ko04911	Insulin secretion	23/358	117/7206	9.85536729117e-09
ko04514	Cell adhesion molecules (CAMs)	23/358	130/7206	7.83883718771e-08
ko04010	MAPK signaling pathway	38/358	321/7206	4.59173769987e-07
ko05014	Amyotrophic lateral sclerosis (ALS)	16/358	74/7206	4.72343446234e-07
ko04261	Adrenergic signaling in cardiomyocytes	27/358	205/7206	2.81250028233e-06
ko04725	Cholinergic synapse	23/358	160/7206	3.53014078836e-06
ko04720	Long-term potentiation	17/358	99/7206	6.13691485606e-06
ko04020	Calcium signaling pathway	31/358	265/7206	7.51889605181e-06
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	14/358	79/7206	2.82173416608e-05
ko04726	Serotonergic synapse	19/358	137/7206	4.19904890583e-05
ko04930	Type II diabetes mellitus	11/358	54/7206	5.42945610484e-05
ko04921	Oxytocin signaling pathway	24/358	209/7206	0.000119054356113
ko04260	Cardiac muscle contraction	14/358	98/7206	0.000313389409799
ko04730	Long-term depression	12/358	78/7206	0.000418477354238
ko05203	Viral carcinogenesis	3/358	277/7206	0.000630740335182
ko04360	Axon guidance	22/358	233/7206	0.00323305648647
ko00604	Glycosphingolipid biosynthesis - ganglio series	4/358	14/7206	0.00403024253163
ko04110	Cell cycle	1/358	145/7206	0.0104237221966
ko05010	Alzheimer's disease	18/358	202/7206	0.0134491349457
ko04915	Estrogen signaling pathway	13/358	131/7206	0.0141469217538
ko04120	Ubiquitin mediated proteolysis	1/358	138/7206	0.0152868328748
ko05410	Hypertrophic cardiomyopathy (HCM)	11/358	100/7206	0.0163443076343
ko03013	RNA transport	2/358	166/7206	0.01755958429
ko05164	Influenza A	2/358	167/7206	0.0176475764228
ko00230	Purine metabolism	3/358	194/7206	0.0187352794613
ko04925	Aldosterone synthesis and secretion	11/358	105/7206	0.019306617764
ko05034	Alcoholism	20/358	238/7206	0.0212696213712
ko01200	Carbon metabolism	1/358	128/7206	0.021620291543
ko04611	Platelet activation	2/358	163/7206	0.025888869626
ko05414	Dilated cardiomyopathy	11/358	112/7206	0.0260434968572
ko04970	Salivary secretion	10/358	95/7206	0.0266522501505
ko04742	Taste transduction	7/358	61/7206	0.0305858819596
ko05162	Measles	1/358	120/7206	0.0312016801525
ko05205	Proteoglycans in cancer	6/358	271/7206	0.0314608629295
ko02024	Quorum sensing	3/358	15/7206	0.0354486105687
ko05168	Herpes simplex infection	3/358	182/7206	0.0359853147558
ko04022	cGMP-PKG signaling pathway	18/358	216/7206	0.0363362808753
ko04150	mTOR signaling pathway	3/358	184/7206	0.0365426085611
ko04151	PI3K-Akt signaling pathway	11/358	390/7206	0.0416344415404
ko04810	Regulation of actin cytoskeleton	6/358	264/7206	0.0417352350297
ko02025	Biofilm formation - Pseudomonas aeruginosa	1/358	1/7206	0.0496808215375